sur Carl Zeiss Meditec AG (ETR:AFX)
Bronwyn Brophy O'Connor Appointed CEO of Carl Zeiss Meditec Group
On December 1, 2026, Bronwyn Brophy O'Connor will step into the role of CEO at Carl Zeiss Meditec AG. The announcement, made on October 26, 2026, marks a significant leadership change as she takes over from interim CEO Andreas Pecher. Brophy O'Connor, with robust credentials from Vitrolife Group in Sweden, will also join the Executive Board of Carl Zeiss AG, managing the Medical Technology segment.
This transition is poised to bolster Carl Zeiss Meditec's innovation and customer-focused growth. Her extensive background, spanning multiple international companies like Johnson & Johnson and Medtronic, equips her well for the strategic development of the group's medical technology efforts. Chairman Peter Kameritsch and Dr. Michael Bolle anticipate her strong leadership will further the company's transformation and success.
R. E.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Carl Zeiss Meditec AG